Are age, anthropometry and components of metabolic syndrome-risk factors interrelated with lower urinary tract symptoms in patients with erectile dysfunction? A prospective study

Aim: To evaluate the effects of metabolic profiles on lower urinary tract symptoms (LUTS) in men with erectile dysfunction (ED). Methods: A total of 75 impotent men aged 25–75 years old (mean 58.1 years) were included in the study on a prospective basis. Patients were evaluated with a complete histo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asian journal of andrology 2007-03, Vol.9 (2), p.213-220
Hauptverfasser: Paick, Jae‐Seung, Yang, Ji‐Hyun, Kim, Soo‐Woong, Ku, Ja‐Hyeon, Prins, Gail S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim: To evaluate the effects of metabolic profiles on lower urinary tract symptoms (LUTS) in men with erectile dysfunction (ED). Methods: A total of 75 impotent men aged 25–75 years old (mean 58.1 years) were included in the study on a prospective basis. Patients were evaluated with a complete history, physical examination, anthropometry and metabolic profiles. LUTS were assessed using the International Prostate Symptom Score (IPSS). Results: Overall, there was no correlation between the IPSS and continuous parameters. However, when continuous variables were categorized, some parameters were significantly associated with LUTS. Patients with triglyceride level of 150 mg/dL or higher had more severe symptoms than those with tiglyceride levels less than 150 mg/dL (19.4 ± 2.4 vs. 14.3 ± 1.1, P= 0.033). When 40 mg/dL was chosen as the high‐density lipoprotein (HDL)‐cholesterol cutoff level, the IPSS was significantly different between the two groups divided by 40 mg/dL (19.4 ± 2.6 for HDL‐cholesterol < 40 mg/dL vs. 14.4 ± 1.0 for HDL‐cholesterol ≥ 40 mg/dL, P= 0.042). The area under the receiver operating characteristic curve (AUROCC) of triglyceride was 65.7% (95% confidence interval [CI], 52.6%‐82.3%; P= 0.034) for severe LUTS. However, the AUROCC for‘HDL‐cholesterol’was not significant (area, 65.4%; 95% CI, 48.2%–82.7%; P= 0.062). No other factors were determined to be significant in this regard. Conclusion: The results of the present study indicate that some metabolic profiles might influence LUTS in men with ED.
ISSN:1008-682X
1745-7262
DOI:10.1111/j.1745-7262.2007.00211.x